One such company, FlowMetric has worked to develop its flow cytometry and immunohistochemistry methods, helping illuminate protein samples without compromising their integrity so that researchers can get the most out of each microscope slide. In an attempt to continue the company’s evolution, FlowMetric has selected the Pennsylvania Biotechnology Center as the location for its new clinical and medical diagnostic laboratory.
We are very excited to be moving into the Pennsylvania Biotechnology
Center, says Renold Capocasale, founder & CEO of FlowMetric. The
Center offers state-of-the-art facilities and a collaborative environment of scientists and business innovators.
As a senior researcher for Johnson & Johnson‘s research laboratory Centocor Discovery Research, Capocasale founded FlowMetric to establish a niche market in the burgeoning Pennsylvania life science and research sector. Now that his company has clients ranging from bio-pharmaceutical researchers to
niche drug discovery companies, Capocasale sought a location with
high-tech labs and instrumentation, but also a research-based
environment that values collaboration and would allow FlowMetric to work with both
entrepreneurs and other scientists.
Established in 2006 by the Hepatitis B Foundation and owned in partnership with Delaware Valley College, the PA Biotechnology Center is a designated Keystone Innovation Zone, focused on quality scientific research as much as networking, collaboration and job creation. FlowMetric finally found a place to hang its hat. And with crisp, clean laboratories awaiting his arrival, Capocasale won’t have to do a black light test before moving in.
The energy created in this type of community will foster FlowMetrics
growth and continuous innovation in our service offerings, says
Capocasale.
Source: Renold Capocasale, FlowMetric
Writer: John Steele